Thursday, 15 October 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 16, 2026

Zacks Investment Ideas feature highlights: Taiwan Semiconductor, NVIDIA, Apple, Broadcom and Meta Platforms

View original at finance.yahoo.com
Zacks Investment Ideas feature highlights: Taiwan Semiconductor, NVIDIA, Apple, Broadcom and Meta Platforms For Immediate Release Chicago, IL – January 16, 2026 – Today, Zacks Investment Ideas feature highlights Taiwan Semiconductor TSM, NVIDIA NVDA, Apple AAPL, Broadcom AVGO and Meta Platforms META…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Aggressive investment reflects sustained AI-driven demand and tight supply conditions

    80% confidence
  • CoWoS capacity is sold out through at least mid-2026

    80% confidence
  • Operating profit margin expected between 54% and 56% for Q1 2026

    80% confidence
  • AI infrastructure buildout will cross $1 trillion annually in 2028

    80% confidence
  • It takes two to three years to build a new fab and new capacity won't meaningfully help supply until 2028 or 2029

    80% confidence
  • A16 node remains on track for volume production in the second half of 2026

    80% confidence
  • For advanced nodes (3nm and 5nm), current demand is roughly three times higher than available capacity

    80% confidence
  • 2nm revenue will surpass the total of 3nm and 5nm by Q3 2026

    80% confidence
  • Early interest for A16 from HPC and AI customers is extremely high

    80% confidence
  • Our pricing will remain strategic, not opportunistic

    80% confidence
  • Gross profit margin expected between 63% and 65% for Q1 2026

    80% confidence
  • AI infrastructure buildout will cross $1 trillion annually in 2028, with as much as 1/3 going for chips

    80% confidence
  • Q1 2026 revenue will fall between $34.6 and $35.8 billion

    80% confidence
  • TSM shares can go to $500 in 2027

    80% confidence
  • Buy TSM shares under $350

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com